Found 10 matching trials
Effects of FTY720 on Heart and Lung Functions in Healthy Volunteers PHASE1 This study is designed to assess the effects of two doses of FTY720 on lung...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase PHASE3 This study assessed the safety, tolerability, and efficacy of 2 doses of or...
Show More Location
North Central Neurology Associates, PC, 1809 Kress Street
Learn More & Join Trial
Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis (MS) PHASE2 To provide efficacy and safety data of two doses (0.5 mg and 1.25 mg) of FT...
Show More Location
Novartis Investigative site
Learn More & Join Trial
Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients PHASE3 To assess safety and tolerability of patients converting from approved Rela...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis PHASE3 This study assessed the safety, tolerability and efficacy of two doses of o...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
An Extension Study of the Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing Multiple Sclerosis PHASE2 This study was an extension study of NCT00537082. This study was designed t...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis PHASE3 This extension study of was designed to evaluate the long-term safety, tole...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis PHASE2 This study evaluated the safety, tolerability and effect on MRI lesion para...
Show More Location
Novartis Investigational site
Learn More & Join Trial
This Was an Open-label, Single-arm Extension Study (CFTY720D2306E1) to a Double-blind, Randomized Multicenter, Placebo-controlled, Parallel-group Core Study (CFTY720D2306) in PPMS. PHASE3 The purpose of this study is to evaluate whether FTY720 is effective in del...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis PHASE3 This study assessed the efficacy, safety, and tolerability of 2 doses of or...
Show More Location
The Queen Elizabeth Hospital
Learn More & Join Trial